Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yujia Zheng, Yulin Liu, Songfeng Zhao, Zhetian Zheng, Chunyi Shen, Li An & Yongliang Yuan. (2018) Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma. Cancer Management and Research 10, pages 6079-6096.
Read now
Read now
Articles from other publishers (19)
Yi-Jie Zhang & De-Hui Yi. (2023) CDK1-SRC Interaction-Dependent Transcriptional Activation of HSP90AB1 Promotes Antitumor Immunity in Hepatocellular Carcinoma. Journal of Proteome Research 22:12, pages 3714-3729.
Crossref
Crossref
Guang-ya Liu, Wei Zhang, Xu-chi Chen, Wen-juan Wu & Shi-qian Wan. (2021) Diagnostic and Prognostic Significance of Keap1 mRNA Expression for Lung Cancer Based on Microarray and Clinical Information from Oncomine Database. Current Medical Science 41:3, pages 597-609.
Crossref
Crossref
Dongling Zhu, Dong Kuang, Sijuan Zou, Lixing Chen, Yuanli Zhu & Xiaohua Zhu. (2019) Immunohistochemical panel of glypican-3, hepatocyte paraffin antigen-1, arginase-1, cytokeratin-19, and human epithelial membrane antigen for the differential diagnosis of liver tumors*. Oncology and Translational Medicine 5:4, pages 153-161.
Crossref
Crossref
Wei Liu, Songyun Ouyang, Zhigang Zhou, Meng Wang, Tingting Wang, Yu Qi, Chunling Zhao, Kuisheng Chen & Liping Dai. (2018) Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databases. Molecular Genetics & Genomic Medicine 7:2.
Crossref
Crossref
Xi-Dai Long, Wei-Zhong Tang, Jun Lu, Xiao-Ying Huang, Jin-Guang Yao, Tian-Qi Zhang, Xing-Zhizi Wang, Qun-Ying Su, Chun-Ying Luo, Xue-Ming Wu, Chao Wang, Li-Xia Zeng, Qiang Xia & Yun Ma. 2018. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment.
Yutao Gao, Xia Liu, Ting Li, Luwei Wei, Antai Yang, Yi Lu, Jian Zhang, Li Li, Sumei Wang & Fuqiang Yin. (2017) Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer. Oncology Reports.
Crossref
Crossref
Fuqiang Yin, Lipei Shu, Xia Liu, Ting Li, Tao Peng, Yueli Nan, Shu Li, Xiaoyun Zeng & Xiaoqiang Qiu. (2016) Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Crossref
Nicolas Goossens & Yujin Hoshida. (2016) Tratamiento personalizado del carcinoma hepatocelular basado en información molecular: perspectivas futuras. Clinical Liver Disease 8:S1, pages S43-S48.
Crossref
Crossref
Yan Li, Weizhong Zhang, Anne Doughtie, Guozhen Cui, Xuanyi Li, Harshul Pandit, Yingbin Yang, Suping Li & Robert Martin. (2016) Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma. Oncotarget 7:32, pages 52329-52339.
Crossref
Crossref
Bin Lu, Yuchen Sheng, Jiaqi Zhang, Zhiyong Zheng & Lili Ji. (2016) The altered microRNA profile in andrographolide-induced inhibition of hepatoma tumor growth. Gene 588:2, pages 124-133.
Crossref
Crossref
Yi-Lin Wang, Chi-mei Chen, Xiao-Ming Wang & Lu Wang. (2016) Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 40:1, pages 51-56.
Crossref
Crossref
Lindsay Y King, Claudia Canasto-Chibuque, Kara B Johnson, Shun Yip, Xintong Chen, Kensuke Kojima, Manjeet Deshmukh, Anu Venkatesh, Poh Seng Tan, Xiaochen Sun, Augusto Villanueva, Angelo Sangiovanni, Venugopalan Nair, Milind Mahajan, Masahiro Kobayashi, Hiromitsu Kumada, Massimo Iavarone, Massimo Colombo, Maria Isabel Fiel, Scott L Friedman, Josep M Llovet, Raymond T Chung & Yujin Hoshida. (2015) A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration. Gut 64:8, pages 1296-1302.
Crossref
Crossref
Nicolas Goossens & Yujin Hoshida. (2015) Personalized management of hepatocellular carcinoma based on molecular information: Future prospects. Clinical Liver Disease 5:6, pages 132-135.
Crossref
Crossref
Nicolas GoossensYujin Hoshida. (2015) Hepatitis C virus-induced hepatocellular carcinoma. Clinical and Molecular Hepatology 21:2, pages 105.
Crossref
Crossref
Yujin Hoshida, Bryan C. Fuchs, Nabeel Bardeesy, Thomas F. Baumert & Raymond T. Chung. (2014) Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. Journal of Hepatology 61:1, pages S79-S90.
Crossref
Crossref
Colles Price & Jianjun Chen. (2014) MicroRNAs in cancer biology and therapy: Current status and perspectives. Genes & Diseases 1:1, pages 53-63.
Crossref
Crossref
Rafael Valencia-Quintana, Juana Sánchez-Alarcón, MarÃa G. Tenorio-Arvide, Youjun Deng, José M. R. Montiel-González, Sandra Gómez-Arroyo, Rafael Villalobos-Pietrini, Josefina Cortés-Eslava, Ana R. Flores-Márquez & Francisco Arenas-Huertero. (2014) The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review. Frontiers in Microbiology 5.
Crossref
Crossref
XIAOYUN ZENG, FUQIANG YIN, XIA LIU, JIANWEN XU, YANG XU, JINMEI HUANG, YUELI NAN & XIAOQIANG QIU. (2014) Upregulation of E2F transcription factor 3 is associated with poor prognosis in hepatocellular carcinoma. Oncology Reports 31:3, pages 1139-1146.
Crossref
Crossref
Xiao-lin Zhu, Yan-li Wang, Jie-peng Chen, Li-li Duan, Pei-fang Cong, Ying-chun Qu, Jesse Li-Ling & Mei-xia Zhang. (2013) Alternol inhibits migration and invasion of human hepatocellular carcinoma cells by targeting epithelial-to-mesenchymal transition. Tumor Biology 35:2, pages 1627-1635.
Crossref
Crossref